肾动脉瘤单纯弹簧圈栓塞与支架辅助弹簧圈栓塞的中期结果
回顾性纳入2015年8月至2019年6月40例肾动脉瘤患者,26例行单纯弹簧圈栓塞(CE),14例行支架辅助弹簧圈栓塞(SCE)。两组技术成功率97.5%,无死亡或动脉瘤破裂,随访期间无复发或瘤囊增大,SCE可能有助于防止宽颈动脉瘤中弹簧圈移位。
要点
- CE与SCE治疗肾动脉瘤中期均安全有效,无死亡、破裂或复发。
- SCE组瘤颈更宽(1.07±0.42 cm vs 0.63±0.37 cm,P=0.021)。
- 两组部分肾梗死发生率及随访肾功能无显著差异。
核心结论
- CE和SCE治疗肾动脉瘤均安全有效,SCE可能在部分宽颈动脉瘤患者中防止弹簧圈移位。
研究设计与样本
- 回顾性研究纳入2015年8月至2019年6月40例接受CE或SCE治疗的肾动脉瘤患者,CE组26例,SCE组14例。
主要发现
- CE组与SCE组平均瘤径分别为2.5±1.5 cm和2.2±0.8 cm(P=0.52)。
- CE组与SCE组瘤颈宽度分别为0.63±0.37 cm和1.07±0.42 cm(P=0.021)。
- 总体技术成功率为97.5%,围术期部分肾梗死发生率CE组12%、SCE组7.1%(P=0.45)。
- 随访期间CE组17.4%、SCE组30.8%发生部分肾梗死,但总体肾功能保持正常。
- 随访期间两组均无动脉瘤复发、瘤囊增大或死亡。
关键数值与推荐
- CE组影像随访平均8.8±9.4个月,SCE组16.1±16.3个月(P=0.158)。
- CE组电话/门诊随访平均20.8±11.3个月,SCE组22.7±16.5个月(P=0.703)。
临床怎么用
- 对肾动脉瘤患者,CE和SCE均可作为安全有效的血管内治疗选择。
- 对宽颈肾动脉瘤,可考虑SCE以降低弹簧圈移位风险。
局限性
- 本研究为单中心回顾性研究,样本量较小(40例),随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coil embolization (CE) alone and stent-assisted coil embolization (SCE) are two major endovascular techniques to treat renal artery aneurysms (RAAs). This study aimed at providing safety and efficacy data of CE and SCE for RAAs. METHODS: Between August 2015 and June 2019, 40 RAA patients treated with CE or SCE were included in the retrospective study. Patients' demographics, clinical manifestations, aneurysm characteristics, treatment strategies, and follow-up results were collected and analyzed. RESULTS: There were 26 and 14 patients in the CE and SCE group, respectively. The mean aneurysm diameter was 2.5 ± 1.5 cm and 2.2 ± 0.8 cm (CE versus SCE, P = 0.52). The neck width of the aneurysm was 0.63 ± 0.37 cm and 1.07 ± 0.42 cm (CE versus SCE, P = 0.021). Technical success was achieved in 97.5% patients. No death or aneurysm rupture occurred. During the perioperative period, 12% and 7.1% patients suffered partial renal infarction (CE versus SCE, P = 0.45). The mean duration of follow-up was 8.8 ± 9.4 months and 16.1 ± 16.3 months (CE versus SCE, P = 0.158) by imaging and 20.8 ± 11.3 and 22.7 ± 16.5 months by visit/telephone (CE versus SCE, P = 0.703). During the follow-up, 17.4% patients in the CE group and 30.8% patients in the SCE group suffered partial renal infarction, while their overall renal function remained normal. In addition, there was no aneurysm recurrence, sac enlargement, or death in both groups. CONCLUSIONS: Both CE and SCE were safe and effective to treat RAAs. In addition, SCE may prevent coil migration in the wide neck aneurysm in selected patients.
引用
- Ma T, He Y, Zhong W, et al. Mid-term Results of Coil Embolization Alone and Stent-assisted Coil Embolization for Renal Artery Aneurysms. Ann Vasc Surg. 2020. PMID: 33387622. doi:10.1016/j.avsg.2020.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。